AI & Software Platforms

Facing declining revenue, Cardlytics brings back former CFO David Evans, who led its 2018 IPO, in a strategic bet on experience for its next chapter.

A breakthrough genetic test helps prostate cancer patients avoid severe side effects from radiation while saving the healthcare system millions of dollars.

With a key drill target identified at its Rio Tinto-partnered project in Montana, the junior explorer is poised for a pivotal year in the hunt for copper.

Pharma giant GSK partners with biotech CAMP4, leveraging novel RNA-boosting tech to develop new therapies for neurodegenerative and kidney diseases.

A landmark partnership and new support programs show how a Florida company is weaving community outreach into its core business strategy to tackle critical needs.

An eight-figure deal for Redwire's docking systems is set to equip The Exploration Company's Nyx capsule, marking a key step for European space autonomy.

A new FDA approval for an EGFR-mutated lung cancer therapy cuts treatment from hours to minutes, offering new hope and convenience for thousands of patients.

With FDA approval for a pivotal study, Pulse Biosciences' novel nanosecond ablation technology aims to make atrial fibrillation treatment safer and more precise.

A new partnership aims to build a secure battery supply chain for drones and UAMs, directly responding to US defense restrictions on Chinese tech.

Hainan launches unprecedented island-wide customs operations, aiming to become a global trade hub. But can it balance openness with control and rival giants?

The automaker adopts advanced IP management software to protect its innovations in EVs and autonomous driving, signaling a critical industry-wide shift.

The Pilates Academy just won a top U.S. award. We explore how its online model is disrupting traditional fitness training and setting new industry standards.

Molecular Partners readies for a pivotal presentation at the J.P. Morgan conference, showcasing its next-gen DARPin therapeutics for hard-to-treat cancers.

Completing a key mission 5 months early, Rocket Lab deployed novel DiskSat tech, cementing its role in the U.S. military's agile space strategy.

With a bold IPO filing, Boumarang plans to leverage hydrogen power, advanced AI, and maritime drones to challenge giants in the booming autonomous systems market.

A Utah biotech reports promising results for a novel mRNA therapy that makes cancer cells look like measles, setting the stage for crucial animal trials.

At JSHG 2025, Nabsys presents its OhmX platform, a breakthrough in electronic genome mapping that promises to solve rare disease mysteries and advance cancer research.

An international expert panel endorses an advanced wound therapy, potentially revolutionizing patient recovery and boosting a key player in the med-tech market.

Kasm Technologies and F5 are uniting to redefine secure remote access, blending containerized VDI with advanced security for the modern enterprise.

A 120-day 'Cape to Cape' voyage introduces complimentary expedition adventures, setting a new standard for ultra-luxury world cruising.